Back
Neurocrine Biosciences, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$131.57
Seasonality Move:
9.25%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and NBIX is experiencing slight selling pressure.
Neurocrine Biosciences, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 130.54 | Buy |
| 20-day SMA: | 129.75 | Buy |
| 50-day SMA: | 131.92 | Sell |
| 200-day SMA: | 137.2 | Sell |
| 8-day EMA: | 130.75 | Buy |
| 20-day EMA: | 130.4 | Buy |
| 50-day EMA: | 132.31 | Sell |
| 200-day EMA: | 134.59 | Sell |
Neurocrine Biosciences, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 52.3 | Buy |
| Chaikin Money Flow: | -104205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (128.42 - 131.9) | Buy |
| Bollinger Bands (100): | (129.64 - 146.68) | Sell |
Neurocrine Biosciences, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences, Inc. Stock
Is Neurocrine Biosciences, Inc. Stock a Buy?
-
Neurocrine Biosciences, Inc. share price is 131.60 while NBIX 8-day simple moving average is 130.54, which is a Buy signal.
-
The stock price of NBIX is 131.60 while Neurocrine Biosciences, Inc. 20-day SMA is 129.75, which makes it a Buy.
-
Neurocrine Biosciences, Inc. 50-day simple moving average is 131.92 while NBIX share price is 131.60, making it a Sell technically.
-
NBIX stock price is 131.60 and Neurocrine Biosciences, Inc. 200-day simple moving average is 137.20, creating a Sell signal.
NBIX Technical Analysis vs Fundamental Analysis
Sell
50
Neurocrine Biosciences, Inc. (NBIX)
is a Sell
Is Neurocrine Biosciences, Inc. a Buy or a Sell?
-
Neurocrine Biosciences, Inc. stock is rated a SellThe current Neurocrine Biosciences, Inc. [NBIX] share price is $131.60. The Score for NBIX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Neurocrine Biosciences, Inc. Stock Info
Market Cap:
13.1B
Price in USD:
131.60
Share Volume:
706.7K
Neurocrine Biosciences, Inc. 52-Week Range
52-Week High:
160.18
52-Week Low:
84.23
Sell
50
Neurocrine Biosciences, Inc. (NBIX)
is a Sell
Neurocrine Biosciences, Inc. Share Price Forecast
-
What is the Neurocrine Biosciences, Inc. stock price today?The Neurocrine Biosciences, Inc. stock price is 131.60 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences, Inc. is overvalued.
Is Neurocrine Biosciences, Inc. Stock a Buy?
-
Neurocrine Biosciences, Inc. share price is 131.60 while NBIX 8-day exponential moving average is 130.75, which is a Buy signal.
-
The stock price of NBIX is 131.60 while Neurocrine Biosciences, Inc. 20-day EMA is 130.40, which makes it a Buy.
-
Neurocrine Biosciences, Inc. 50-day exponential moving average is 132.31 while NBIX share price is 131.60, making it a Sell technically.
-
NBIX stock price is 131.60 and Neurocrine Biosciences, Inc. 200-day simple moving average is 134.59, creating a Sell signal.
Fundamental Analysis of Neurocrine Biosciences, Inc.
Is Neurocrine Biosciences, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.21 per share, an increase this year of $1.15 per share, and an increase next year of $1.76 per share.
Technical Analysis of Neurocrine Biosciences, Inc.
Should I short Neurocrine Biosciences, Inc. stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Neurocrine Biosciences, Inc. is a Sell
-
Neurocrine Biosciences, Inc. Relative Strength Index (RSI) is 52.3, which suggest Neurocrine Biosciences, Inc. is overbought
-
The Bollinger Bands (25) for Neurocrine Biosciences, Inc. is (128.42 - 131.9), which suggest Neurocrine Biosciences, Inc. is a Sell
-
The Bollinger Bands (100) for Neurocrine Biosciences, Inc. is (129.64 - 146.68), which suggest Neurocrine Biosciences, Inc. is a Sell
* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.